肝细胞癌
心理干预
医学
肝癌
光学(聚焦)
管理策略
重症监护医学
内科学
计算机科学
业务
护理部
光学
物理
工商管理
作者
María Reig,Alejandro Forner,Jordi Rimola,Joana Ferrer-Fábrega,Marta Burrel,Ángeles García‐Criado,Robin Kate Kelley,Peter R. Galle,Vincenzo Mazzaferro,Riad Salem,Bruno Sangro,Amit G. Singal,Arndt Vogel,Josep Fuster,Carmen Ayuso,Jordi Bruix
标识
DOI:10.1016/j.jhep.2021.11.018
摘要
There have been major advances in the armamentarium for hepatocellular carcinoma (HCC) since the last official update of the Barcelona Clinic Liver Cancer prognosis and treatment strategy published in 2018. Whilst there have been advances in all areas, we will focus on those that have led to a change in strategy and we will discuss why, despite being encouraging, data for select interventions are still too immature for them to be incorporated into an evidence-based model for clinicians and researchers. Finally, we describe the critical insight and expert knowledge that are required to make clinical decisions for individual patients, considering all of the parameters that must be considered to deliver personalised clinical management.
科研通智能强力驱动
Strongly Powered by AbleSci AI